Verdauungskrankheiten, Jahrgang 44 (2026) - März/April (89 - 95)

Endoscopic resection of Barrett’s neoplasia: when EMR, when ESD?
A. Probst
Universitätsklinikum Augsburg, III. Medizinische Klinik, Augsburg

Add to Cart  

 

DOI 10.5414/VDX01313

Abstrakt

Endoscopic resection (ER) is the treatment of choice for Barrett`s associated early neoplasia. Histopathologic criteria (invasion depth, grade of differentiation, lymphovascular invasion) have to be taken into account to achieve curative resections. ER techniques include endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD). In meta-analyses ESD is shown to be superior regarding en bloc resection, R0 resection and recurrence rate. Complication rates are comparable. National and international guidelines give different recommendations for the use of EMR and ESD in Barrett`s neoplasia. When early adenocarcinoma is suspected or histologically proven R0 resection should be the aim of ER. As ESD guarantees higher R0 resection rates, ESD should be favoured over EMR. EMR should be restricted for ER of small flat lesions.

Autoreninformation

Autoren

Abteilungen

  • Universitätsklinikum Augsburg, III. Medizinische Klinik, Augsburg

Adresse

Dr. Andreas Probst
Universitätsklinikum Augsburg
III. Medizinische Klinik
Stenglinstrasse 2
86156 Augsburg
Email: [email protected]

Citation

A. Probst.Resektion von Barrettfrühneoplasien: wann EMR, wann ESD?. 2026; 44: 89-95. doi: 10.5414/VDX01313.

###article_not_exists_msg###

Warenkorb Übersicht

Warenkorb Übersicht
Typ Anz Rabatt MwSt Preis
Der Warenkorb ist leer
Ihr Warenkorb